# MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

> **NCT06735508** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** mRNA Neoantigen Vaccine
- **DRUG:** Adebrelimab

## Key facts

- **NCT ID:** NCT06735508
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06735508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06735508, "MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06735508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*